4,4,5,5-Tetramethyl-2-(naphthalen-2-yl)-1,3,2-dioxaborolane, 95.0%, 5g

m-PEG6-CH2CH2CHO, 1g

n-(4-(Hydroxymethyl)thiazol-2-yl)acetamide, 95+%, 1g

4-(aminomethyl)-1-tert-butylpyrrolidin-2-one hydrochloride, 95.0%, 250mg

2-(5-Bromo-2-methylbenzyl)-5-(4-fluorophenyl)thiophene, 95.0%, 1g

(2-Butoxy-5-chlorophenyl)boronic acid, 95.0%, 1g

5-Bromo-3-methyl-7-azaindole, 97.0%, 1g

1,3-Bis(2,6-diisopropylphenyl)imidazolium Chloride>98.0%(HPLC)(T)5g

(trans,trans)-4'-Propyl-[1,1'-bi(cyclohexan)]-4-ol, 95.0%, 25g

1-(3-chloro-4-methylphenyl)-5-phenyl-4,5-dihydro-1H-pyrazole-3-carboxylic acid, 95.0%, 1g

Agitatore per incubazione SI-200D, 1 pezzo

Ethyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiophene-2-carboxylate, 95.0%, 250mg

4-[(Piperidin-4-yl)oxy]piperidine-1-carboxylic acid tert-butyl ester, 97%, 5g